OriCell Therapeutics (Shanghai) Co., Ltd.
Total Funding
$120 Million
Total Rounds
1
First Raise
Aug 1, 2022
Latest Raise
Aug 1, 2022
Organization Chart
Founders and leadership hierarchy for this company.
Contact details require Sales or Enterprise
All Funding Rounds
| Date | Deal Type | Amount | Lead Investor |
|---|---|---|---|
| 8/1/2022 | Series B | $120 Million | Qiming Venture Partners, Quan Capital |
Company Performance Metrics
Premium Feature
Upgrade to Premium to view Capital Momentum Score and performance metrics